Literature DB >> 17601625

Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex.

S Cafaggi1, E Russo, R Stefani, R Leardi, G Caviglioli, B Parodi, G Bignardi, D De Totero, C Aiello, M Viale.   

Abstract

In this work, nanoparticles with a negative or positive surface charge were prepared through electrostatic interaction of an anionic cisplatin-alginate complex with a cationic polyelectrolyte, namely chitosan or N-trimethyl chitosan (substitution degree of 85%). Statistical experimental design allowed the study of the influence of component amounts on the characteristics of nanoparticles. Mean particle diameter ranged from 180 nm to 350 nm. After 24 h, while the cisplatin-alginate complex released almost all the drug in saline-buffered solution at pH 7.4, approximately 40% w/w of total cisplatin was released from negative nanoparticles and roughly 50% w/w from positive ones. The same cumulative amounts of released drug were found after 48 h, with a progressive reduction to lower values up to 6 days. Drug loading of nanoparticles with a positive zeta potential (43 mV-60 mV) ranged from 13% w/w to 21% w/w and particle yield, referred to total polymers, was about 15% w/w (50% w/w if referred to cisplatin-alginate complex). Nanoparticles with a negative zeta potential (-34 mV) were obtained with a yield of 40% w/w and a drug loading of 18% w/w. These nanoparticles were the least active on all cell lines tested, while the cytotoxic activity of the positive nanoparticles was similar to or lower than that of cisplatin, probably depending on the combination of sizes and zeta potential values, on P388 murine and A2780 human cells. On A549 human cells, the nanoparticles with the smallest size and the lowest positive zeta potential were more active than cisplatin and showed a similar capability in inducing apoptosis in A2780 human cells. These results indicate that cisplatin complexes with polycarboxylate polymers can be transformed into cisplatin particulate carriers of high potential interest.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17601625     DOI: 10.1016/j.jconrel.2007.05.037

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  18 in total

1.  Cisplatin-loaded porous Si microparticles capped by electroless deposition of platinum.

Authors:  Jennifer S Park; Joseph M Kinsella; Danielle D Jandial; Stephen B Howell; Michael J Sailor
Journal:  Small       Date:  2011-06-01       Impact factor: 13.281

2.  Synthesis and characterization of collagen/hydroxyapatite: magnetite composite material for bone cancer treatment.

Authors:  Ecaterina Andronescu; Maria Ficai; Georgeta Voicu; Denisa Ficai; Maria Maganu; Anton Ficai
Journal:  J Mater Sci Mater Med       Date:  2010-04-07       Impact factor: 3.896

3.  Preparation, characterization, and cellular uptake of resveratrol-loaded trimethyl chitosan nanoparticles.

Authors:  Jeong Bin Min; Eun Suh Kim; Ji-Soo Lee; Hyeon Gyu Lee
Journal:  Food Sci Biotechnol       Date:  2017-12-13       Impact factor: 2.391

4.  Pulmonary delivery of cisplatin-hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer.

Authors:  Yumei Xie; Kristin L Aillon; Shuang Cai; Jason M Christian; Neal M Davies; Cory J Berkland; M Laird Forrest
Journal:  Int J Pharm       Date:  2010-04-02       Impact factor: 5.875

5.  A Comparative Study Between the Antibacterial Effect of Nisin and Nisin-Loaded Chitosan/Alginate Nanoparticles on the Growth of Staphylococcus aureus in Raw and Pasteurized Milk Samples.

Authors:  Maryam Zohri; Mohammad Shafiee Alavidjeh; Ismaeil Haririan; Mehdi Shafiee Ardestani; Seyed Esmaeil Sadat Ebrahimi; Hadi Tarighati Sani; Seyed Kazem Sadjadi
Journal:  Probiotics Antimicrob Proteins       Date:  2010-12       Impact factor: 4.609

Review 6.  Polysaccharide-Based Controlled Release Systems for Therapeutics Delivery and Tissue Engineering: From Bench to Bedside.

Authors:  Tianxin Miao; Junqing Wang; Yun Zeng; Gang Liu; Xiaoyuan Chen
Journal:  Adv Sci (Weinh)       Date:  2018-01-08       Impact factor: 16.806

7.  Enhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations.

Authors:  Prakash Ramalingam; Young Tag Ko
Journal:  Pharm Res       Date:  2014-08-01       Impact factor: 4.200

Review 8.  Trimethyl chitosan and its applications in drug delivery.

Authors:  V K Mourya; Nazma N Inamdar
Journal:  J Mater Sci Mater Med       Date:  2008-12-27       Impact factor: 3.896

9.  Caprylate-conjugated Cisplatin for the development of novel liposomal formulation.

Authors:  Imran Vhora; Nirav Khatri; Jagruti Desai; Hetal Paresh Thakkar
Journal:  AAPS PharmSciTech       Date:  2014-04-04       Impact factor: 3.246

Review 10.  Nanoparticle formulations of cisplatin for cancer therapy.

Authors:  Xiaopin Duan; Chunbai He; Stephen J Kron; Wenbin Lin
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.